UNIVERSITY OF NOTTINGHAM (THE)
Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study.
This is a contract result notice, not an open opportunity. Details from the official award data.
This sits in the upper-middle of the Research & Development band — a substantial contract for the sector. Based on 20,405 valued Research & Development tenders in our corpus.
The Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study in naive and cancer xenograft bearing mice of our HER2 targeting apoferritin anti-cancer drug delivery platform.
Make the case to bid
Reveal who to approach at UNIVERSITY OF NOTTINGHAM (THE), and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
- OCID
- b7fe11c2-b9bc-4f06-8d38-f5d56d677deb
- Stage
- contract · Contract
- Source
- Contracts Finder
- Buyer ref
- Medicines Discovery Catapult.
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Research & Development
UNIVERSITY OF NOTTINGHAM (THE)’s tender network